Search Results - "MESSER, LAUREL H."

Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System by Messer, Laurel H, Forlenza, Gregory P, Sherr, Jennifer L, Wadwa, R Paul, Buckingham, Bruce A, Weinzimer, Stuart A, Maahs, David M, Slover, Robert H

“…The MiniMed 670G System is the first commercial hybrid closed-loop (HCL) system for management of type 1 diabetes. Using data from adolescent and young adult…”
Get full text

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial by Forlenza, Gregory P, Ekhlaspour, Laya, Breton, Marc, Maahs, David M, Wadwa, R Paul, DeBoer, Mark, Messer, Laurel H, Town, Marissa, Pinnata, Jennifer, Kruse, Geoff, Buckingham, Bruce A, Cherñavvsky, Daniel

“…Hybrid closed-loop (HCL) artificial pancreas (AP) systems are now moving from research settings to widespread clinical use. In this study, the inControl…”
Get more information

Closed loop control in adolescents and children during winter sports: Use of the Tandem Control‐IQ AP system by Ekhlaspour, Laya, Forlenza, Gregory P., Chernavvsky, Daniel, Maahs, David M., Wadwa, R. Paul, Deboer, Mark D., Messer, Laurel H., Town, Marissa, Pinnata, Jennifer, Kruse, Geoff, Kovatchev, Boris P., Buckingham, Bruce A., Breton, Marc D.

“…Objective Artificial pancreas (AP) systems have been shown to improve glycemic control throughout the day and night in adults, adolescents, and children…”
Get full text

CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring by Messer, Laurel H., Cook, Paul F., Tanenbaum, Molly L., Hanes, Sarah, Driscoll, Kimberly A., Hood, Korey K.

“…Background: Continuous glucose monitors (CGM) are underutilized by individuals with type 1 diabetes (T1D), particularly during the adolescent years. Little is…”
Get full text

The Increasing Onset of Type 1 Diabetes in Children by Hummel, Kevin, BS, McFann, Kim K., PhD, Realsen, Jaime, BS, Messer, Laurel H., MPH, Klingensmith, Georgeanna J., MD, Chase, H. Peter, MD

“…Objective To identify trends in the recent onset of type 1 diabetes (T1D) in Colorado youth seen at the Barbara Davis Center (BDC) and compare these changes…”
Get full text

The dawn of automated insulin delivery: A new clinical framework to conceptualize insulin administration by Messer, Laurel H., Forlenza, Gregory P., Wadwa, R. Paul, Weinzimer, Stuart A., Sherr, Jennifer L., Hood, Korey K., Buckingham, Bruce A., Slover, Robert H., Maahs, David M.

Get full text

Why Expectations Will Determine the Future of Artificial Pancreas by Messer, Laurel H

Get more information

Hybrid Closed-Loop Systems to Date: Hype Versus Reality by Messer, Laurel H, Berget, Cari

Get more information

A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm by Messer, Laurel H, Berget, Cari, Forlenza, Gregory P

Get more information

Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial by Laffel, Lori M, Kanapka, Lauren G, Beck, Roy W, Bergamo, Katherine, Clements, Mark A, Criego, Amy, DeSalvo, Daniel J, Goland, Robin, Hood, Korey, Liljenquist, David, Messer, Laurel H, Monzavi, Roshanak, Mouse, Thomas J, Prahalad, Priya, Sherr, Jennifer, Simmons, Jill H, Wadwa, R. Paul, Weinstock, Ruth S, Willi, Steven M, Miller, Kellee M

“…IMPORTANCE: Adolescents and young adults with type 1 diabetes exhibit the worst glycemic control among individuals with type 1 diabetes across the lifespan…”
Get full text

Real world hybrid closed‐loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months by Messer, Laurel H., Berget, Cari, Vigers, Tim, Pyle, Laura, Geno, Cristy, Wadwa, R. Paul, Driscoll, Kimberly A., Forlenza, Gregory P.

“…Objective To describe predictors of hybrid closed loop (HCL) discontinuation and perceived barriers to use in youth with type 1 diabetes. Subjects Youth with…”
Get full text

Six months of hybrid closed loop in the real‐world: An evaluation of children and young adults using the 670G system by Berget, Cari, Messer, Laurel H., Vigers, Tim, Frohnert, Brigitte I., Pyle, Laura, Wadwa, R. Paul, Driscoll, Kimberly A., Forlenza, Gregory P.

“…Objective To describe glycemic and psychosocial outcomes in youth with type 1 diabetes using a hybrid closed loop (HCL) system. Subjects Youth with type 1…”
Get full text

Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical Care by Messer, Laurel H, Breton, Marc D

“…To determine insulin dosing parameters that are associated with and predict optimal outcomes for people using t:slim X2 with Control-IQ technology (CIQ)…”
Get more information

MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy by Saunders, Aria, Messer, Laurel H, Forlenza, Gregory P

“…: Automated insulin delivery for people with type 1 diabetes has been a major goal in the diabetes technology field for many years. While a fully automated…”
Get more information

Real-World Diabetes Technology: Overcoming Barriers and Disparities by Messer, Laurel H, Addala, Ananta, Weinzimer, Stuart A

Get more information

Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study by Breton, Marc D, Cherñavvsky, Daniel R, Forlenza, Gregory P, DeBoer, Mark D, Robic, Jessica, Wadwa, R Paul, Messer, Laurel H, Kovatchev, Boris P, Maahs, David M

“…Intense exercise is a major challenge to the management of type 1 diabetes (T1D). Closed-loop control (CLC) systems (artificial pancreas) improve glycemic…”
Get full text

Preserving Skin Integrity with Chronic Device Use in Diabetes by Messer, Laurel H, Berget, Cari, Beatson, Christie, Polsky, Sarit, Forlenza, Gregory P

“…Skin integrity and diabetes device placement are ongoing concerns for people with diabetes who utilize continuous glucose monitors (CGMs) and continuous…”
Get more information

Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes by Messer, Laurel H, Berget, Cari, Pyle, Laura, Vigers, Timothy, Cobry, Erin, Driscoll, Kimberly A, Forlenza, Gregory P

“…To describe real-world outcomes for youth using the Tandem t:slim X2 insulin pump with Control-IQ technology ("Control-IQ") for 6 months at a large pediatric…”
Get more information

Effect of Verapamil on Pancreatic Beta Cell Function in Newly Diagnosed Pediatric Type 1 Diabetes: A Randomized Clinical Trial by Forlenza, Gregory P, McVean, Jennifer, Beck, Roy W, Bauza, Colleen, Bailey, Ryan, Buckingham, Bruce, DiMeglio, Linda A, Sherr, Jennifer L, Clements, Mark, Neyman, Anna, Evans-Molina, Carmella, Sims, Emily K, Messer, Laurel H, Ekhlaspour, Laya, McDonough, Ryan, Van Name, Michelle, Rojas, Diana, Beasley, Shannon, DuBose, Stephanie, Kollman, Craig, Moran, Antoinette

“…IMPORTANCE: In preclinical studies, thioredoxin-interacting protein overexpression induces pancreatic beta cell apoptosis and is involved in…”
Get full text

Real‐world performance of hybrid closed loop in youth, young adults, adults and older adults with type 1 diabetes: Identifying a clinical target for hybrid closed‐loop use by Berget, Cari, Akturk, Halis Kaan, Messer, Laurel H., Vigers, Timothy, Pyle, Laura, Snell‐Bergeon, Janet, Driscoll, Kimberly A., Forlenza, Gregory P.

“…Aim To describe real‐world hybrid closed loop (HCL) use and glycaemic outcomes across the lifespan and identify a clinical threshold for HCL use associated…”
Get full text